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Enzymatic synthesis of N-acetyllactosamine from lactose enabled 
ďǇƌĞĐŽŵďŝŶĂŶƚɴ ? ? ?-galactosyltransferases  
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Utilising a fast and sensitive screening method based on 
imidazolium-tagged probes, we report unprecedented reversible 
ĂĐƚŝǀŝƚǇ ŽĨ ďĂĐƚĞƌŝĂů ɴ ? ? ?-galactosyltransferases to catalyse the 
transgalactosylation from lactose to N-acetylglucosamine to form 
N-acetyllactosamine in the presence of UDP. The process is 
demonstrated by the preparative scale synthesis of pNP-ɴ-LacNAc 
ĨƌŽŵ ůĂĐƚŽƐĞ ƵƐŝŶŐ ɴ ? ? ?-galactosyltransferase NmLgtB-B as the 
only biocatalyst. 
     Galactosides are among the most abundant glycans in the 
mammalian glycome and are generally biosynthesised by 
Leloir galactosyltransferases. In particular, N-
acetyllactosamine (LacNAc) is a common core glycan motif 
(e.g., Type 2 glycans) in free oligosaccharides, glycoproteins 
and glycolipids. Galactosides, including LacNAc, are 
important constituents of human milk oligosaccharides, 
which have great health benefits for infants.
1,2 
Sialylated and 
fucosylated LacNAc such as sialyl Lewis
X
 have been described 
as ligands of various lectins, such as selectins.
3 
The demand 
of galactosides for biological investigation and 
commercialisation as additives to formula milk has increased 
considerably over the last decade and synthetic methods 
employing biocatalysts are very attractive compared to 
multi-step chemical strategies.
4 W10
  
      The central role of galactosides in these bioactive 
oligosaccharides, in particular LacNAc (1), has prompted the 
development of several enzymatic synthetic strategies 
(Scheme 1). Key to all is the activation of the galactose  
 
Scheme 1. Enzymatic approaches for LacNAc derivative (1) 
synthesis using GlcNAc-R as acceptor and 2-5 as donor 
substrates. 
 
anomeric centre, since direct glycosidic bond formation from 
free reducing sugars is unfavourable. In biosynthesis, UDP-
galactose (2) is commonly utilised as the activated substrate 
by a wide range of galactosyltransferases, but the cost of this 
substrate can be prohibitive in large scale synthesis. 
      Several elegant alternative synthetic approaches have 
been developed using activated substrates such as galactosyl 
fluoride (3) 
11
 and pNP-galactose (4).
12
 UDP-galactose (2) can 
also be regenerated using a multienzyme system from either 
galactose or sucrose, which adds additional steps and 
potential side-products.
13 W15
 It has been recognised that the 
most cost-efficient galactosyl donor would be lactose (5), a 
waste product of the cheese industry that is produced at >6 
million ton scale every year. So far, the use of lactose as 
substrate has been limited to galactosidases, which have 
some inherent transgalactosylation activity, but show 
generally poor regioselectivity and low yield.
16,17
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      These findings prompted us to look for biocatalysts that 
would be able to generate the donor UDP-galactose (2) 
directly in situ from lactose and UDP without any further 
cofactor. In general, Leloir glycosyltransferases are perceived 
to catalyse unidirectional reactions.
18
 However, the 
reversible catalytic activity of natural product 
glycosyltransferases has been described,
19
 and subsequently 
employed to synthesise a wealth of different nucleotide 
sugars in the presence of nucleotides.
20
 Leloir 
glycosyltransferases such as sucrose synthase
21
 ĂŶĚ ɲ ?ɲ-
trehalose synthase
22
 were widely used to produce nucleotide 
diphosphate glucose based on its reversible activity. 
Furthermore, mammalian sialyltransferase ST3Gal-ʳʳ ǁĂƐ
used to synthesise CMP-EĞƵ ?ĐĨƌŽŵɲ ? ? ?ƐŝĂůǇůĂƚĞĚŐůǇĐĂŶƐ
and glycoconjugates in the presence of CMP,
23
 which was 
utilised to label sialic acid containing glycoproteins and 
gangliosides.
24
 ZĞĐĞŶƚůǇ ?ƚǁŽďĂĐƚĞƌŝĂůɲ ? ? ?-sialyltransferases 
ǁĞƌĞ ĞǆƉůŽŝƚĞĚ ĂƐ ƐƉĞĐŝĨŝĐ ɲ ? ? ?-sialidases based on their 
reverse activity.
25,26
 Furthermore, glycosyl transfer catalysed 
ďǇɴ ? ? ?-N-ĂĐĞƚǇůŐůƵĐŽƐĂŵŝŶǇůƚƌĂŶƐĨĞƌĂƐĞʳʳʳ ?'Ŷd-ʳʳʳ ?ǁĂƐĂůƐŽ
reversible.
27
  However, to the best of our knowledge there is 
no report on galactosyltransferases exhibiting reverse 
transfer from lactose.    
       For the initial screening of transgalactosylation activity, it 
was important to develop a fast and robust assay that would 
detect even weak galactose transfer activity in the presence 
of a high excess of lactose. Our previous work had shown 
that sugar acceptors tagged with imidazolium-based probes 
(I-Tags) allow for the monitoring of glycosylation reactions by 
mass spectrometry (MALDI-ToF),
28 W31
 even in complex 
mixtures.
32
 The cationic I-Tag generates a strong MS signal 
that dominates the ionisation of the analytes
31
 and allows for 
a reasonable estimate of overall yields by measurement of 
starting material and product peaks. 
      For the purpose of the present study, a new class of 
benzyl carbamate-containing I-Tagged glucosides of Glc (11) 
and GlcNAc (12) were chemically synthesised from 1-
azidopropyl derivatives 6a
33
 and 6b
30
 in 4 steps, giving 18% 
and 21% overall yield respectively (Scheme 2, see ESI for 
further details). As expected, MALDI-ToF spectra of Glc-ITag 
(11) and GlcNAc-ITag (12) provided strong peaks with 
expected mass in aqueous and buffer solutions (Figure 1). 
Furthermore, when both I-Tagged substrates were treated 
with a galactosyltransferase (NmLgtB-A, see below) and UDP-
Gal (2) the glycosylation products could be clearly observed 
by MALDI-ToF without any further purification (Figure 1), 
providing an excellent basis for further screening studies. 
 
 
Scheme 2. Chemical synthesis of Glc-ITag (11) and GlcNAc-
ITag (12).  
 
Figure 1. MALDI-ToF mass spectra of ITag substrates (11 and 
12, blue traces) and their biotransformation products (13 
and 14, red traces). Glc-ITag 11 [M]
+
 = 466, GlcNAc-ITag 12  
[M]
+
 = 507,  Lac-ITag 13 [M]
+
 = 628 , and LacNAc-ITag 14 [M]
+
 
= 669. 
 
     The I-Tag methodology was next used to screen 
galactosyltransferase activity from lactose (5) instead of 
UDP-Gal (2 ? ? dŚƌĞĞ ďĂĐƚĞƌŝĂů ɴ ? ? ?-galactosyltransferases 
were cloned from Neisseria meningitidis serogroup A strain 
Z2491 (NmLgtB-A), Neisseria meningitidis serogroup B strain 
MC58 (NmLgtB-B)
8
 and Neisseria meningitidis (NmLgtH). 
NmLgtB-A and NmLgtB-B are homologous proteins from 
different strains (92% identity), while NmLgtH shows 71% 
and 72% identity to NmLgtB-A and NmLgtB-B, respectively, 
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as shown by the amino acid sequence alignment (ESI, Figure 
S2). All three proteins were produced recombinantly in E. coli 
BL21 (DE3) with an N-terminal His6-tag, and purified by 
affinity chromatography. In the first instance, the activity of 
the ƚŚƌĞĞɴ ? ? ?-galactosyltransferases was confirmed by using 
Glc-ITag (11) and GlcNAc-ITag (12) as substrates (Scheme 
3A), although LgtH displayed only low activity against 12 
(data not shown).   
     Having established a sensitive MS-based assay on I-
Tagged substrates, lactose (5) was tested as galactose donor 
in the presence of UDP (Scheme 3B). Given that the 
equilibrium between lactose and UDP-Gal would be 
expected to be unfavourable towards the latter, UDP-Gal 
generation was monitored by coupling the reactions with 
subsequent galactose transfer to the I-Tagged acceptor 
substrates 11 and 12 (Scheme 3), which would result in 
transfer of galactose from lactose to substrate via in situ 
formation of UDP-Gal. Rewardingly, formation of Lac-ITag 
(13) and LacNAc-ITag (14) from 11 and 12 (Scheme 3) could 
be detected by MALDI-ToF spectrometry in the NmLgtB-B 
catalysed reactions, while NmLgtB-A afforded only a very low 
conversion and NmLgtH no conversion at all (ESI, Figures S3-
S8). Therefore, NmLgtB-B was used in all subsequent 
experiments. 
 
Scheme 3. Investigation of galactosyltransferase activity with 
I-Tag acceptor substrates 11 and 12. A: using UDP-Gal (2) as 
sugar donor. B: using lactose (5) as sugar donor. 
     The scope of galactose donor substrates beyond lactose 
was also tested using pNP-ɴ-Lac, pNP-ɲ-Gal, pNP-ɴ-Gal and 
LacNAc (1) as galactose donors in the presence of UDP. 
Galactose transfer was also observed in reactions containing 
pNP-ɴ-Lac and LacNAc (ESI, Figures S9-S10). However, since 
lactose (5) is inexpensive and easily available, it was 
subsequently used as a preferable galactose donor. 
     The optimal reaction conditions for the 
transgalactosylation activity of NmLgtB-B were explored by 
studying the effects of pH, UDP concentration and lactose 
concentration on the yield, using pNP-ɴ-GlcNAc (15) as 
acceptor (Figure 2). Interestingly, with NmLgtB-B higher 
conversions could be achieved in acidic environment, with a 
maximum around pH 5.0 (Figure 2A). This could potentially 
be ascribed to the pH-dependent protonation of the beta-
phosphate group in UDP, as previously observed for sucrose 
synthase.
21,34
 In the absence of UDP no conversion was 
observed, suggesting that UDP is required for the transfer 
reaction and providing the first mechanistic clue that the 
reactions would proceed via UDP-Gal (2). Product formation 
increased gradually when the concentration of UDP was 
increased, with a plateau reached at 2 mM (Figure 2B). 
Screening of different lactose (5) concentrations established 
that no significant increases in the conversion could be 
achieved above 20 mM (Figure 2C).  
 
  
Figure 2. Optimisation of the transgalactosylation reaction 
conditions. A: pH dependence, using 1 mM pNP-ɴ-GlcNAc, 5 
mM UDP and 10 mM Lac. B: UDP conc. dependence, using 1 
mM pNP-ɴ-GlcNAc, 10 mM Lac and sodium acetate (SA) 
buffer pH 5.0. C: lactose (5) conc. dependence, using 1 mM 
pNP-ɴ-GlcNAc, 2mM UDP and sodium acetate (SA) buffer pH 
5.0. 
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The formation of UDP-Gal (2) as an intermediate was also 
verified directly by HRMS analysis of the crude incubation 
mixture. In a reaction mixture containing lactose (5), UDP 
and NmLgtB-B in acetate buffer pH 5.0 incubated at 37°੔ 
overnight, it was possible to detect the presence of UDP-Gal 
(2), while a negative control without enzyme did not show 
the diagnostic peaks (ESI, Figure S11). 
     The practical application of galactosylation from lactose 
(5) was demonstrated by the preparative synthesis of pNP-ɴ-
LacNAc (16) (Scheme 4). Initially, a reaction time course was 
carried out to monitor the reaction process. No significant 
product increase was observed after 7 h incubation at 37°੔ 
(ESI, Figure S12). Hence, preparative scale reaction mixture 
containing pNP-ɴ-GlcNAc (15 ?  ? ?ʅŵŽů), lactose (5, 1 mmol) 
ĂŶĚhW ? ? ? ?ʅŵŽů ?ǁĞƌĞŝŶĐƵďĂƚĞĚǁŝƚŚEŵ>Őƚ-B at 37°੔  
for 14 h, affording 90% conversion as measured by HPLC (ESI, 
Figure S13). The unreacted pNP-ɴ-GlcNAc (15) was removed 
ďǇŚǇĚƌŽůǇƐŝƐǁŝƚŚɴ-N-acetylhexosaminidase, which allowed 
for the product to be isolated by preparative reverse-phase 
HPLC, yielding pNP-ɴ-LacNAc (16) in 50% overall yield. 
 
 
 
Scheme 4. Preparative synthesis of pNP-ɴ-LacNAc (16). 
Conclusions 
     The reversibility of the catalytic activity of  Leloir ɴ ? ? ?-
galactosyltransferases, in particular NmLgtB-B, was 
demonstrated for the first time by utilising novel 
imidazolium-tagged substrates.  This reversibility allowed for 
the in situ formation of UDP-Gal (2) from inexpensive lactose 
(5), in the presence of UDP. By adding a further acceptor 
substrate the overall transfer of galactose from lactose (5) to 
acceptor substrates 11, 12 and 15 could be observed. The 
practical applicability of this simple transgalactosylation 
method was demonstrated by preparative scale synthesis of 
pNP-ɴ-LacNAc (16) from lactose using NmLgtB-B as the only 
biocatalyst. The excess of lactose drives the reaction in the 
direction of the formation of 16 efficiently and without side-
products. Even though a large excess of lactose and 
overstoichiometric UDP are required, lactose is a waste 
product of the milk industry and UDP is considerably less 
expensive than the LacNAc derivatives obtained. Therefore, 
our transglycosylation strategy could potentially provide an 
opportunity for converting bio-waste into products with 
higher added value. 
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